drugset / Trial / NCT00882466

The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction

NCT00882466

Phase 4 Completed 58 enrolled Seoul National University Bundang Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the effect of intravenous human recombinant erythropoietin on the reperfusion injury at primary percutaneous coronary intervention in patients with acute myocardial infarction.

Timeline

Start
2008-05
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject epoetin alfa Protein / enzyme biologic 50 iu/kg Intravenous